Condition

Alopecia Areata

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting0

Common interventions4

Lead sponsors shown4

Clinical trials

5 shown

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNCT05635266 · 2021-10-26

UNKNOWN

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicNCT05098600 · 2021-10-15

COMPLETED

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNCT04239521 · 2020-10-01

COMPLETED

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNCT01931644 · 2013-07-01

COMPLETED

Expanded Access to UpadacitinibNCT04159597

AVAILABLE

Common interventions

Exposure of interestOTHER1 Exposure of interest (studies 2 & 3).OTHER1 Specimen sampleDIAGNOSTIC_TEST1 UpadacitinibDRUG1

Leading sponsors

Sanguine Biosciences2 AbbVie1 Faculty Hospital Kralovske Vinohrady1 Momentum Data1

Trial status mix

COMPLETED3

AVAILABLE1

UNKNOWN1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.